Form D · Biotechnology

Kriya Therapeutics, Inc.

Morrisville, NC · CIK 0001811209

Offering snapshot reported Sep 10, 2025 · SEC filing

Reported sold
$321M
Offering amount: $321M
Investors reported
10
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Jul 31, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 10, 2025Amendment$320,822,412No comparison10SEC filing
Aug 15, 2025Initial$313,297,440No comparison2SEC filing
Jul 27, 2023Amendment$361,794,505$91,249,944vs May 24, 202229SEC filing
May 24, 2022Initial$270,544,561No comparison20SEC filing
Jul 14, 2021Initial$99,999,999No comparisonNot reportedSEC filing
Aug 18, 2020Amendment$87,634,885$1,999,999vs May 19, 202021SEC filing
May 19, 2020Initial$85,634,886No comparison20SEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
$0
Finders' fees
$0
Form D file number
021-554967

Source: Form D, filed Sep 10, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Daniel Chen Executive
Katherine Eade Executive
Brian Furmanski Executive
Ryan Gallagher Director
Trit Garg Director
Curt Herberts Executive
Roger Jeffs Director
Dana Johnson Executive
Ilise Lombardo Executive
Keith Manchester Director
James Momtazee Director
Ilan Oren Director
Britt Petty Executive
Akshay Rai Director
Saira Ramasastry Director
Shankar Ramaswamy Director, Executive
Neera Ravindran Executive
C.R. Sincock Director
Michele Stone Executive
Neelaksh Varshney Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
4105 Hopson Road
Morrisville, NC, 27560